Lubricant eye drops used to treat the dryness and irritation associated with deficient tear production in keratoconjunctivitis sicca (dry eyes). They are also used to moisten contact lenses and in eye examinations.
Highlights
The global Eye Drops and Lubricants Drugs market was valued at US$ 9038.4 million in 2022 and is anticipated to reach US$ 9973.9 million by 2029, witnessing a CAGR of 1.4% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
In European market, Eye Drops and Lubricants Drugs key players include ALCON, Allergan, Thea pharmaceuticals, Bausch Health, Johnson & Johnson, etc. European top five players hold a share over 55%. Germany is the largest Eye Drops and Lubricants Drugs market in Europe, with a market share of nearly 20%.
In terms of product, Standard Eye Care is the largest segment, with a share over 80%. And in terms of application, the largest channel is Pharmacy, followed by Grocery, Optical Chains, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Eye Drops and Lubricants Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Eye Drops and Lubricants Drugs.
The Eye Drops and Lubricants Drugs market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Eye Drops and Lubricants Drugs market comprehensively. Regional market sizes, concerning products by type, by channel and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Eye Drops and Lubricants Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by channel and by regions.
By Company
ALCON
Allergan
Thea pharmaceuticals
Bausch Health
Johnson & Johnson
URSAPHARM
OmniVision Pharma
SIMILASAN
Rohto
Akorn
Prestige Consumer Healthcare
Segment by Type
Allergy Eye Care
Standard Eye Care
Segment by Channel
Pharmacy
Internet
Grocery
Optical Chains
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Eye Drops and Lubricants Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Eye Drops and Lubricants Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Eye Drops and Lubricants Drugs 麻豆原创 Overview
1.1 Product Overview and Scope of Eye Drops and Lubricants Drugs
1.2 Eye Drops and Lubricants Drugs Segment by Type
1.2.1 Global Eye Drops and Lubricants Drugs 麻豆原创 Value Comparison by Type (2023-2029)
1.2.2 Allergy Eye Care
1.2.3 Standard Eye Care
1.3 Eye Drops and Lubricants Drugs Segment by Channel
1.3.1 Global Eye Drops and Lubricants Drugs 麻豆原创 Value by Channel: (2023-2029)
1.3.2 Pharmacy
1.3.3 Internet
1.3.4 Grocery
1.3.5 Optical Chains
1.4 Global Eye Drops and Lubricants Drugs 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Eye Drops and Lubricants Drugs Revenue 2018-2029
1.4.2 Global Eye Drops and Lubricants Drugs Sales 2018-2029
1.4.3 Global Eye Drops and Lubricants Drugs 麻豆原创 Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Eye Drops and Lubricants Drugs 麻豆原创 Competition by Manufacturers
2.1 Global Eye Drops and Lubricants Drugs Sales 麻豆原创 Share by Manufacturers (2018-2023)
2.2 Global Eye Drops and Lubricants Drugs Revenue 麻豆原创 Share by Manufacturers (2018-2023)
2.3 Global Eye Drops and Lubricants Drugs Average Price by Manufacturers (2018-2023)
2.4 Global Eye Drops and Lubricants Drugs Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Eye Drops and Lubricants Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Eye Drops and Lubricants Drugs, Product Type & Application
2.7 Eye Drops and Lubricants Drugs 麻豆原创 Competitive Situation and Trends
2.7.1 Eye Drops and Lubricants Drugs 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Eye Drops and Lubricants Drugs Players 麻豆原创 Share by Revenue
2.7.3 Global Eye Drops and Lubricants Drugs 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Eye Drops and Lubricants Drugs Retrospective 麻豆原创 Scenario by Region
3.1 Global Eye Drops and Lubricants Drugs 麻豆原创 Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Eye Drops and Lubricants Drugs Global Eye Drops and Lubricants Drugs Sales by Region: 2018-2029
3.2.1 Global Eye Drops and Lubricants Drugs Sales by Region: 2018-2023
3.2.2 Global Eye Drops and Lubricants Drugs Sales by Region: 2024-2029
3.3 Global Eye Drops and Lubricants Drugs Global Eye Drops and Lubricants Drugs Revenue by Region: 2018-2029
3.3.1 Global Eye Drops and Lubricants Drugs Revenue by Region: 2018-2023
3.3.2 Global Eye Drops and Lubricants Drugs Revenue by Region: 2024-2029
3.4 North America Eye Drops and Lubricants Drugs 麻豆原创 Facts & Figures by Country
3.4.1 North America Eye Drops and Lubricants Drugs 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Eye Drops and Lubricants Drugs Sales by Country (2018-2029)
3.4.3 North America Eye Drops and Lubricants Drugs Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Eye Drops and Lubricants Drugs 麻豆原创 Facts & Figures by Country
3.5.1 Europe Eye Drops and Lubricants Drugs 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Eye Drops and Lubricants Drugs Sales by Country (2018-2029)
3.5.3 Europe Eye Drops and Lubricants Drugs Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Eye Drops and Lubricants Drugs 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Eye Drops and Lubricants Drugs 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Eye Drops and Lubricants Drugs Sales by Country (2018-2029)
3.6.3 Asia Pacific Eye Drops and Lubricants Drugs Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Eye Drops and Lubricants Drugs 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Eye Drops and Lubricants Drugs 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Eye Drops and Lubricants Drugs Sales by Country (2018-2029)
3.7.3 Latin America Eye Drops and Lubricants Drugs Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Eye Drops and Lubricants Drugs 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Eye Drops and Lubricants Drugs 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Eye Drops and Lubricants Drugs Sales by Country (2018-2029)
3.8.3 Middle East and Africa Eye Drops and Lubricants Drugs Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Eye Drops and Lubricants Drugs Sales by Type (2018-2029)
4.1.1 Global Eye Drops and Lubricants Drugs Sales by Type (2018-2023)
4.1.2 Global Eye Drops and Lubricants Drugs Sales by Type (2024-2029)
4.1.3 Global Eye Drops and Lubricants Drugs Sales 麻豆原创 Share by Type (2018-2029)
4.2 Global Eye Drops and Lubricants Drugs Revenue by Type (2018-2029)
4.2.1 Global Eye Drops and Lubricants Drugs Revenue by Type (2018-2023)
4.2.2 Global Eye Drops and Lubricants Drugs Revenue by Type (2024-2029)
4.2.3 Global Eye Drops and Lubricants Drugs Revenue 麻豆原创 Share by Type (2018-2029)
4.3 Global Eye Drops and Lubricants Drugs Price by Type (2018-2029)
5 Segment by Channel
5.1 Global Eye Drops and Lubricants Drugs Sales by Channel (2018-2029)
5.1.1 Global Eye Drops and Lubricants Drugs Sales by Channel (2018-2023)
5.1.2 Global Eye Drops and Lubricants Drugs Sales by Channel (2024-2029)
5.1.3 Global Eye Drops and Lubricants Drugs Sales 麻豆原创 Share by Channel (2018-2029)
5.2 Global Eye Drops and Lubricants Drugs Revenue by Channel (2018-2029)
5.2.1 Global Eye Drops and Lubricants Drugs Revenue by Channel (2018-2023)
5.2.2 Global Eye Drops and Lubricants Drugs Revenue by Channel (2024-2029)
5.2.3 Global Eye Drops and Lubricants Drugs Revenue 麻豆原创 Share by Channel (2018-2029)
5.3 Global Eye Drops and Lubricants Drugs Price by Channel (2018-2029)
6 Key Companies Profiled
6.1 ALCON
6.1.1 ALCON Corporation Information
6.1.2 ALCON Description and Business Overview
6.1.3 ALCON Eye Drops and Lubricants Drugs Sales, Revenue and Gross Margin (2018-2023)
6.1.4 ALCON Eye Drops and Lubricants Drugs Product Portfolio
6.1.5 ALCON Recent Developments/Updates
6.2 Allergan
6.2.1 Allergan Corporation Information
6.2.2 Allergan Description and Business Overview
6.2.3 Allergan Eye Drops and Lubricants Drugs Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Allergan Eye Drops and Lubricants Drugs Product Portfolio
6.2.5 Allergan Recent Developments/Updates
6.3 Thea pharmaceuticals
6.3.1 Thea pharmaceuticals Corporation Information
6.3.2 Thea pharmaceuticals Description and Business Overview
6.3.3 Thea pharmaceuticals Eye Drops and Lubricants Drugs Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Thea pharmaceuticals Eye Drops and Lubricants Drugs Product Portfolio
6.3.5 Thea pharmaceuticals Recent Developments/Updates
6.4 Bausch Health
6.4.1 Bausch Health Corporation Information
6.4.2 Bausch Health Description and Business Overview
6.4.3 Bausch Health Eye Drops and Lubricants Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bausch Health Eye Drops and Lubricants Drugs Product Portfolio
6.4.5 Bausch Health Recent Developments/Updates
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Corporation Information
6.5.2 Johnson & Johnson Description and Business Overview
6.5.3 Johnson & Johnson Eye Drops and Lubricants Drugs Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Johnson & Johnson Eye Drops and Lubricants Drugs Product Portfolio
6.5.5 Johnson & Johnson Recent Developments/Updates
6.6 URSAPHARM
6.6.1 URSAPHARM Corporation Information
6.6.2 URSAPHARM Description and Business Overview
6.6.3 URSAPHARM Eye Drops and Lubricants Drugs Sales, Revenue and Gross Margin (2018-2023)
6.6.4 URSAPHARM Eye Drops and Lubricants Drugs Product Portfolio
6.6.5 URSAPHARM Recent Developments/Updates
6.7 OmniVision Pharma
6.6.1 OmniVision Pharma Corporation Information
6.6.2 OmniVision Pharma Description and Business Overview
6.6.3 OmniVision Pharma Eye Drops and Lubricants Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 OmniVision Pharma Eye Drops and Lubricants Drugs Product Portfolio
6.7.5 OmniVision Pharma Recent Developments/Updates
6.8 SIMILASAN
6.8.1 SIMILASAN Corporation Information
6.8.2 SIMILASAN Description and Business Overview
6.8.3 SIMILASAN Eye Drops and Lubricants Drugs Sales, Revenue and Gross Margin (2018-2023)
6.8.4 SIMILASAN Eye Drops and Lubricants Drugs Product Portfolio
6.8.5 SIMILASAN Recent Developments/Updates
6.9 Rohto
6.9.1 Rohto Corporation Information
6.9.2 Rohto Description and Business Overview
6.9.3 Rohto Eye Drops and Lubricants Drugs Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Rohto Eye Drops and Lubricants Drugs Product Portfolio
6.9.5 Rohto Recent Developments/Updates
6.10 Akorn
6.10.1 Akorn Corporation Information
6.10.2 Akorn Description and Business Overview
6.10.3 Akorn Eye Drops and Lubricants Drugs Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Akorn Eye Drops and Lubricants Drugs Product Portfolio
6.10.5 Akorn Recent Developments/Updates
6.11 Prestige Consumer Healthcare
6.11.1 Prestige Consumer Healthcare Corporation Information
6.11.2 Prestige Consumer Healthcare Eye Drops and Lubricants Drugs Description and Business Overview
6.11.3 Prestige Consumer Healthcare Eye Drops and Lubricants Drugs Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Prestige Consumer Healthcare Eye Drops and Lubricants Drugs Product Portfolio
6.11.5 Prestige Consumer Healthcare Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Eye Drops and Lubricants Drugs Industry Chain Analysis
7.2 Eye Drops and Lubricants Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Eye Drops and Lubricants Drugs Production Mode & Process
7.4 Eye Drops and Lubricants Drugs Sales and 麻豆原创ing
7.4.1 Eye Drops and Lubricants Drugs Sales Channels
7.4.2 Eye Drops and Lubricants Drugs Distributors
7.5 Eye Drops and Lubricants Drugs Customers
8 Eye Drops and Lubricants Drugs 麻豆原创 Dynamics
8.1 Eye Drops and Lubricants Drugs Industry Trends
8.2 Eye Drops and Lubricants Drugs 麻豆原创 Drivers
8.3 Eye Drops and Lubricants Drugs 麻豆原创 Challenges
8.4 Eye Drops and Lubricants Drugs 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
ALCON
Allergan
Thea pharmaceuticals
Bausch Health
Johnson & Johnson
URSAPHARM
OmniVision Pharma
SIMILASAN
Rohto
Akorn
Prestige Consumer Healthcare
听
听
*If Applicable.